Global Protein Drugs Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 91

Report ID: 1955

A type of drugs made of protein. These drugs usually have large molecular weight with proteincharacteristics.
In 2018, the global Protein Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Protein Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Protein Drugs development in United States, Europe and China.

The key players covered in this study
Eli Lilly
Abbott Laboratories
UCB Group
Schering-Plough Corporation
Genentech
Johnson&Johnson
Bristol-Myers Squibb
Novo Nordisk
Biogen Idec
Dendreon Corporation
Amgen Inc.

Market segment by Type, the product can be split into
Antibody Drugs
Peptide Hormones
Blood Products
Enzymes

Market segment by Application, split into
Hospitals
Clinics
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Protein Drugs status, future forecast, growth opportunity, key market and key players.
To present the Protein Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Protein Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Protein Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Antibody Drugs
1.4.3 Peptide Hormones
1.4.4 Blood Products
1.4.5 Enzymes
1.5 Market by Application
1.5.1 Global Protein Drugs Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Protein Drugs Market Size
2.2 Protein Drugs Growth Trends by Regions
2.2.1 Protein Drugs Market Size by Regions (2014-2025)
2.2.2 Protein Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Protein Drugs Market Size by Manufacturers
3.1.1 Global Protein Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Protein Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Protein Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Protein Drugs Key Players Head office and Area Served
3.3 Key Players Protein Drugs Product/Solution/Service
3.4 Date of Enter into Protein Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Protein Drugs Market Size by Type (2014-2019)
4.2 Global Protein Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Protein Drugs Market Size (2014-2019)
5.2 Protein Drugs Key Players in United States
5.3 United States Protein Drugs Market Size by Type
5.4 United States Protein Drugs Market Size by Application

6 Europe
6.1 Europe Protein Drugs Market Size (2014-2019)
6.2 Protein Drugs Key Players in Europe
6.3 Europe Protein Drugs Market Size by Type
6.4 Europe Protein Drugs Market Size by Application

7 China
7.1 China Protein Drugs Market Size (2014-2019)
7.2 Protein Drugs Key Players in China
7.3 China Protein Drugs Market Size by Type
7.4 China Protein Drugs Market Size by Application

8 Japan
8.1 Japan Protein Drugs Market Size (2014-2019)
8.2 Protein Drugs Key Players in Japan
8.3 Japan Protein Drugs Market Size by Type
8.4 Japan Protein Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Protein Drugs Market Size (2014-2019)
9.2 Protein Drugs Key Players in Southeast Asia
9.3 Southeast Asia Protein Drugs Market Size by Type
9.4 Southeast Asia Protein Drugs Market Size by Application

10 India
10.1 India Protein Drugs Market Size (2014-2019)
10.2 Protein Drugs Key Players in India
10.3 India Protein Drugs Market Size by Type
10.4 India Protein Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Protein Drugs Market Size (2014-2019)
11.2 Protein Drugs Key Players in Central & South America
11.3 Central & South America Protein Drugs Market Size by Type
11.4 Central & South America Protein Drugs Market Size by Application

12 International Players Profiles
12.1 Eli Lilly
12.1.1 Eli Lilly Company Details
12.1.2 Company Description and Business Overview
12.1.3 Protein Drugs Introduction
12.1.4 Eli Lilly Revenue in Protein Drugs Business (2014-2019)
12.1.5 Eli Lilly Recent Development
12.2 Abbott Laboratories
12.2.1 Abbott Laboratories Company Details
12.2.2 Company Description and Business Overview
12.2.3 Protein Drugs Introduction
12.2.4 Abbott Laboratories Revenue in Protein Drugs Business (2014-2019)
12.2.5 Abbott Laboratories Recent Development
12.3 UCB Group
12.3.1 UCB Group Company Details
12.3.2 Company Description and Business Overview
12.3.3 Protein Drugs Introduction
12.3.4 UCB Group Revenue in Protein Drugs Business (2014-2019)
12.3.5 UCB Group Recent Development
12.4 Schering-Plough Corporation
12.4.1 Schering-Plough Corporation Company Details
12.4.2 Company Description and Business Overview
12.4.3 Protein Drugs Introduction
12.4.4 Schering-Plough Corporation Revenue in Protein Drugs Business (2014-2019)
12.4.5 Schering-Plough Corporation Recent Development
12.5 Genentech
12.5.1 Genentech Company Details
12.5.2 Company Description and Business Overview
12.5.3 Protein Drugs Introduction
12.5.4 Genentech Revenue in Protein Drugs Business (2014-2019)
12.5.5 Genentech Recent Development
12.6 Johnson&Johnson
12.6.1 Johnson&Johnson Company Details
12.6.2 Company Description and Business Overview
12.6.3 Protein Drugs Introduction
12.6.4 Johnson&Johnson Revenue in Protein Drugs Business (2014-2019)
12.6.5 Johnson&Johnson Recent Development
12.7 Bristol-Myers Squibb
12.7.1 Bristol-Myers Squibb Company Details
12.7.2 Company Description and Business Overview
12.7.3 Protein Drugs Introduction
12.7.4 Bristol-Myers Squibb Revenue in Protein Drugs Business (2014-2019)
12.7.5 Bristol-Myers Squibb Recent Development
12.8 Novo Nordisk
12.8.1 Novo Nordisk Company Details
12.8.2 Company Description and Business Overview
12.8.3 Protein Drugs Introduction
12.8.4 Novo Nordisk Revenue in Protein Drugs Business (2014-2019)
12.8.5 Novo Nordisk Recent Development
12.9 Biogen Idec
12.9.1 Biogen Idec Company Details
12.9.2 Company Description and Business Overview
12.9.3 Protein Drugs Introduction
12.9.4 Biogen Idec Revenue in Protein Drugs Business (2014-2019)
12.9.5 Biogen Idec Recent Development
12.10 Dendreon Corporation
12.10.1 Dendreon Corporation Company Details
12.10.2 Company Description and Business Overview
12.10.3 Protein Drugs Introduction
12.10.4 Dendreon Corporation Revenue in Protein Drugs Business (2014-2019)
12.10.5 Dendreon Corporation Recent Development
12.11 Amgen Inc.

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details